Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Total Assets (Quarterly) : 285.13M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 285.13M |
| March 31, 2026 | 434.57M |
| December 31, 2025 | 396.90M |
| September 30, 2025 | 396.06M |
| June 30, 2025 | 342.95M |
| March 31, 2025 | 327.21M |
| December 31, 2024 | 350.91M |
| September 30, 2024 | 389.52M |
| June 30, 2024 | 395.62M |
| March 31, 2024 | 438.82M |
| December 31, 2023 | 471.07M |
| September 30, 2023 | 524.06M |
| June 30, 2023 | 603.22M |
| March 31, 2023 | 1.155B |
| December 31, 2022 | 1.101B |
| September 30, 2022 | 1.040B |
| June 30, 2022 | 975.69M |
| March 31, 2022 | 1.083B |
| December 31, 2021 | 1.127B |
| September 30, 2021 | 1.079B |
| June 30, 2021 | 1.007B |
| March 31, 2021 | 599.34M |
| December 31, 2020 | 559.24M |
| September 30, 2020 | 492.32M |
| June 30, 2020 | 443.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 404.00M |
| December 31, 2019 | 402.75M |
| September 30, 2019 | 334.34M |
| June 30, 2019 | 315.72M |
| March 31, 2019 | 363.54M |
| December 31, 2018 | 332.05M |
| September 30, 2018 | 416.65M |
| June 30, 2018 | 618.22M |
| March 31, 2018 | 571.10M |
| December 31, 2017 | 605.67M |
| September 30, 2017 | 625.09M |
| June 30, 2017 | 705.08M |
| March 31, 2017 | 701.32M |
| December 31, 2016 | 709.82M |
| September 30, 2016 | 731.98M |
| June 30, 2016 | 700.21M |
| March 31, 2016 | 603.32M |
| December 31, 2015 | 619.12M |
| September 30, 2015 | 613.43M |
| June 30, 2015 | 653.94M |
| March 31, 2015 | 305.53M |
| December 31, 2014 | 333.51M |
| September 30, 2014 | 346.17M |
| June 30, 2014 | 371.06M |
| March 31, 2014 | 418.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 135.12B |
| Rigel Pharmaceuticals, Inc. | 521.07M |
| Marker Therapeutics, Inc. | 14.59M |
| Verastem, Inc. | 206.51M |
| Theriva Biologics, Inc. | 34.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 446.97M |
| Shareholders Equity (Quarterly) | -161.84M |
| Debt to Equity Ratio | -2.452 |
| Current Ratio | 6.063 |
| Net Debt Paydown Yield | 5.81% |